Skip to main content
. 2016 Aug 11;6:31477. doi: 10.1038/srep31477

Figure 3. Time trends from 2011 to 2015.

Figure 3

Percentages per months for first-time initiators of vitamin K antagonists (VKA), dabigatran, rivaroxaban, and apixaban from 22 August 2011 to 31 December 2015.